Endometrial endometrioid adenocarcinoma: A pathologic analysis of 827 consecutive cases

American Journal of Clinical Pathology

Volumn 129, Issue 1, 2008, Pages 110-114

  Nofech Mozes, Sharon ^a   Ghorab, Zeina ^a   Ismiil, Nadia ^a   Ackerman, Ida ^b   Thomas, Gillian ^b   Barbera, Lisa ^b   Covens, Al ^b   Khalifa, Mahmond A ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Binary grading; Cervical involvement; Endometrial cancer; Lymphovascular invasion; Myoinvasion; Pathologic features; Staging

Indexed keywords

CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA; ENDOMETRIUM CARCINOMA; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LYMPH NODE; OVARY METASTASIS; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE; ADULT; AGED; ARTICLE; CANCER INVASION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; METASTASIS; MIDDLE AGED; MYOMETRIUM; OVARY; OVARY TUMOR; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; OVARY;

EID: 38449105047     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/UDYANQ6XTK6UUTXQ     Document Type: Review

References (25)

1. Canadian Cancer Statistics 2007. Available at http://www.cancer.ca/vgn/ images/portal/cit_86751114/36/15/ 1816216925cw_2007stats_en.pdf. Accessed October 23, 2007.
2. Abeler VM, Kjorstad KE, Berle E. Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population. Int J Gynecol Cancer. 1992;2:9-22.
3. International Federation of Gynecology and Obstetrics. Corpus cancer staging [news]. Int J Gynecol Obstet. 1989;28:189-190.
4. Cress RD, Morris C, Ellison GL, et al. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001. Cancer. 2006;107(5 suppl):1142-1152.
5. Shen Y, Yang Y, Inoue LY, et al. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst. 2005;97:1195-1203.
6. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
7. Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer. 2004;100:1035-1044.
8. Kotake K, Honjo S, Sugihara K, et al. Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum. 2003;46(10 suppl):S32-S43.
9. Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, et al. Colon cancer in France: evidence for improvement in management and survival. Gut. 2002;51:60-64.
10. Cress RD, Morris CR, Wolfe BM. Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med. 2000;31:447-453.
11. Alkushi A, Abdul-Rahman ZH, Lim P, et al. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol. 2005;29:295-304.
12. Scholten AN, Smit VT, Beerman H, et al. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma. Cancer. 2004;100:764-772.
13. Khalifa MA, Dodge J, Covens A, et al. Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy. Gynecol Oncol. 2003;90:425-430.
14. Chan JK, Cheung MK, Huh WK, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006;107:1823-1830.
15. Inoue Y, Obata K, Abe K, et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer. 1996;78:1447-1451.
16. Lachance JA, Everett EN, Greer B, et al. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol. 2006;101:470-475.
17. Aalders JG, Thomas G. Endometrial cancer: revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol. 2007;104:222-231.
18. Kirby TO, Leath CA III, Kilgore LC. Surgical staging in endometrial cancer. Oncology (Huntingt). 2006;20:45-50.
19. Greven KM, Corn B W. Endometrial cancer. Curr Probl Cancer. 1997;21:65-127.
20. Zaino RJ, Kurman RJ, Diana KL, et al. Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage: a Gynecologic Oncology Group study. Cancer. 1996;77:1115-1121.
21. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer. 1987;60 (8 suppl):2035-2041.
22. Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984;63:825-832.
23. Kwon JS, Carey MS, Cook E F, et al. Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study. Int J Gynecol Cancer. 2007;17:433-440.
24. Partridge EE, Shingleton HM, Menck HR. The National Cancer Data Base report on endometrial cancer. J Surg Oncol. 1996;61:111-123.
25. Roland PY, Kelly FJ, Kulwicki CY, et al. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol Oncol. 2004;93:125-130.